ArticleBone marrow transplantation2026
Successful treatment with Tislelizumab and Zanubrutinib in a patient with relapsed/refractory, CD19/CD20 negative Richter's transformed CLL.
Rina Latscha et al.PubMed ↗Publisher ↗
No numbers read from the abstract.